期刊文献+

幽门螺杆菌hpaA真核表达质粒的构建及鉴定 被引量:2

Construction and identification of eukaryotic expression plasmid of hpaA of H.pylori
在线阅读 下载PDF
导出
摘要 目的 克隆幽门螺杆菌hpaA基因,并构建其真核表达质粒。方法 以HpNCTC11637基因组DNA为模板, PCR扩增hpaA基因,亚克隆至pMD18 T载体中,目的基因经酶切纯化后插入pTCAE,转化E.coliDH5α,酶切并测序鉴定正 确的重组质粒命名为pT hpaA。电穿孔法将pT hpaA转染CHO细胞,Westernblot检测HpaA蛋白的表达。结果 克隆重组 得到pT hpaA,将pT hpaA电穿孔法转染CHO后,培养上清经Westernblot检测,在相对分子量为30000条带处出现特异性抗 原抗体反应。结论 成功构建了幽门螺杆菌hpaA真核表达质粒,体外CHO细胞转染和Westernblot实验证实了HpaA蛋 白的表达,为进一步的免疫实验奠定了基础。 Objective To clone hpaA gene of H.pylori and construct its eukaryotic expression plasmid. Methods Gene hpaA amplificated from genome of H.pylori 11637 strain by PCR was subcloned into pMD18-T vector. Then hpaA cut down from the vector with restriction enzyme was inserted to pTCAE, and the product confirmed by restriction enzyme digestion and sequence was transformed to E.coli DH5α. pT-hpaA was transfected into CHO cell by electroporation, and HpaA protein was detected by Western blot. Results hpaA gene was inserted into pTCAE and the immunological reaction band with anti-HpaA serum at MW 30 000 was detected by Western blot. Conclusion Eukaryotic expression plasmid of hpaA of H.pylori is successfully constructed. Western blot analysis demonstrates that the expression of HpaA protein can be detected in culture supernatants of transfeced CHO cells, which lays the foundation for the further study.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第6期547-549,共3页 Journal of Third Military Medical University
基金 国家"863"计划资助项目(2001AA215161)~~
关键词 HELICOBACTER PYLORI HPAA DNA疫苗 Helicobacter pylori hpaA DNA vaccine
  • 相关文献

参考文献12

  • 1Korn C, Meiss G, Gast F, et al. Genetic engineering of Escherichia coli to produce a 1: 1 complex of the anabaena sp. PCC 7120 nuclease NucA and its inhibitor NuiA[J]. Gene, 2000, 253(2): 221-229.
  • 2Kiefer H, Vogel R, Maier Kee, et al . Bacterial expression of G-protein- coupled receptors: prediction of expression levels from sequence[J]. Receptors Channels, 2000, 7(2): 109-119.
  • 3Amemiya K, Granger R P, Dalakas M C. DegP-coexpression minimizes inclusion-body formation upon overproduction of recombinant penicillin acylase in Escherichia coli[J]. Biotechnol Bioeng, 2001, 73(6): 484-492.
  • 4Lee J H, Kim J H, Hwang S W, et al. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies[J]. Biochem Biophys Res Commun, 2000, 277(3): 575-580.
  • 5Correa P. Helicobacter pylori and gastric carcinogenesis[J]. Am J Surg Pathol, 1995, 19(Suppl 1): S37-43.
  • 6Indresh K S, Margaret A L. Gene vaccine[J]. Ann Intern Med, 2003, 138: 550-559.
  • 7Leal H Y, Torres J, Monath T P, et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection[J]. Am J Gastroenterol, 2003, 98(11): 2395-2402.
  • 8Todoroki I, Joh T, Watanabe K, et al. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice[J]. BBRC, 2000, 277(1): 159-163.
  • 9Miyashita M, Joh T i, Watanabe K, et al. Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori catalase[J]. Vaccine, 2002, 20(17-18): 2336-2342.
  • 10Evans D J, Evans D G. Helicobacter pylori adhesins: review and perspectives[J]. Helicobacter, 2000, 5(4): 183-195.

同被引文献16

  • 1徐灿,李兆申,屠振兴,许国铭,杜奕奇,孙波,杨骅,龚燕芳,金晶,吴红玉.幽门螺杆菌hpaA核酸疫苗的构建及免疫原性检测[J].中华消化杂志,2004,24(10):579-582. 被引量:3
  • 2Loughlin MF.Novel therapeutic targets in Helicobacter pylori.E xpert Opin Ther Targets,2003,7:725-735.
  • 3JieYan YafeiMao ZhexinShao.Frequencies of the expression of mai n protei n antigens from Helicobacter pylori isolates and production of specific serum an tibodies in infected patients[J].世界胃肠道学杂志(英文版),2005,3:367-369.
  • 4Lamarque D,M Peek R Jr.Pathogenesis of Helicobacter pylori infectio n.Helic obacter,2003,8(Suppl 1):21-30.
  • 5Srivastava I K, Liu M A. Gene vaccines[J]. Ann Intern Med, 2003,138(7): 550 -559.
  • 6Corthesy Theulaz I. Vaccination against Helicobacterpylori[J]. Recent Results Cancer Res, 2000, 156: 55 - 59.
  • 7Todoroki I, Joh T, Watanabe K, et al. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice [ J]. Biochem Biophys Res Commun, 2000, 277 (1):159 - 163.
  • 8Wu Y Z, Zhao J P, Wan Y, et al. Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo[J]. J Virol, 2002, 76(20): 10264 -10269.
  • 9Corthesy Theulaz I, Porta N, Glauser M, et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice[J]. Gastroenterology, 1995, 109(1 ): 115- 121.
  • 10Kim B O, Shin S S, Yoo Y H, et al. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits[J]. Clin Sci (Lond), 2001, 100(3): 291 -298.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部